Cytta Corp.
CYCA · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | 0.61 | 0.07 |
| FCF Yield | -2.72% | -3.68% | -4.14% | -3.90% |
| EV / EBITDA | -20.63 | 1.58 | -17.75 | -14.99 |
| Quality | ||||
| ROIC | -8.57% | -8.94% | -120.93% | -58.20% |
| Gross Margin | -3,071.63% | -1,391.75% | 51.71% | 100.00% |
| Cash Conversion Ratio | 0.10 | -0.06 | 0.63 | 0.53 |
| Growth | ||||
| Revenue 3-Year CAGR | 17.71% | 32.07% | 54.84% | -9.64% |
| Free Cash Flow Growth | 44.04% | 12.17% | -7.28% | 35.30% |
| Safety | ||||
| Net Debt / EBITDA | 0.30 | -0.05 | -0.70 | 0.00 |
| Interest Coverage | -26.35 | -7.93 | -9.61 | -10.98 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -2,945.19 | -2,651.65 | -4,321.22 |